Ledger.Open graph →
SEC Form D · filed February 20, 2026

ILIAD BIOTECHNOLOGIES, INC

Offering
$115.5M
Sold
$115.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WESTON, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

William A. Langan · WILMINGTON, DEExec · DirectorJesus Correa · Costa Mesa, CADirectorMichelle Guber · Fort Lauderdale, FLDirectorWilliam Steinkrauss · Weston, FLExecMario Barro · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗